Skip to main content

5 Result(s)

within Saori Tatsuno Remove this filter

and

  1. Article

    Open Access

    Manual on the proper use of the 211At-labeled PSMA ligand ([211At]PSMA-5) for clinical trials of targeted alpha therapy (1st edition)

    Recently, an astatine-labeled prostate-specific membrane antigen (PSMA) ligand ([211At]PSMA-5) has been developed for the targeted alpha therapy of patients with prostate cancer. This manual delineates its physic...

    Tadashi Watabe, Masao Namba, Sachiko Yanagida… in Annals of Nuclear Medicine (2024)

    Download PDF (576 KB) View Article

  2. No Access

    Article

    Clinical outcomes and failure patterns after postoperative radiotherapy for oral cavity squamous cell carcinoma

    This study aimed to assess recurrence patterns and identify the optimal dose and target volumes of postoperative radiotherapy (PORT) in patients with oral cavity squamous cell carcinoma (OSCC).

    Saori Tatsuno, Hiroshi Doi MD, PhD, Masahiro Inada… in Strahlentherapie und Onkologie (2024)

  3. No Access

    Article

    Clinical course of longer than five years after definitive radiotherapy for nasopharyngeal carcinoma

    This study aimed to reveal the long-term outcomes and late toxicities (> 5 years) after definitive intensity-modulated radiation therapy (IMRT) in patients with nasopharyngeal carcinoma (NPC).

    Hiroshi Doi, Aritoshi Ri, Masahiro Inada… in International Journal of Clinical Oncology (2023)

  4. No Access

    Article

    Difference in failure patterns after stereotactic body radiotherapy for lung cancer according to clinical T stage based on 4D computed tomography

    Stereotactic body radiotherapy (SBRT) is a treatment option for early-stage lung cancer. We aimed to examine the differences in failure patterns after SBRT according to the clinical T stage.

    Takaya Inagaki, Hiroshi Doi MD PhD, Masahiro Inada… in Strahlentherapie und Onkologie (2023)

  5. Article

    Open Access

    Risk factors for radiation pneumonitis after rotating gantry intensity-modulated radiation therapy for lung cancer

    The risk factors for severe radiation pneumonitis (RP) in patients with lung cancer who undergo rotating gantry intensity-modulated radiation therapy (IMRT) using volumetric modulated arc therapy (VMAT) or hel...

    Saori Tatsuno, Hiroshi Doi, Wataru Okada, Eri Inoue… in Scientific Reports (2022)

    Download PDF (1736 KB) View Article